The global drug safety solutions and pharmacovigilance market is expected to grow at a CAGR of 6.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing number of clinical trials, growing demand for personalized medicine, and increasing awareness about adverse drug reactions. The global drug safety solutions and pharmacovigilance market is segmented on the basis of type into standard form, customized form, and drug safety solutions; on the basis of application into biotechnology and pharmaceuticals, contract research organization (CROS), hospital, KPO/BPO healthcare institutions; on the basis of region into North America (NA), Latin America (LA), Europe (EU), Asia Pacific (APAC) Middle East & Africa (MEA). 2) Increasing number of clinical trials 3) Increasing awareness about adverse drug reactions (ADRs) among healthcare professionals and patients.
Some Of The Growth Factors Of This Market:
- Increasing awareness about adverse drug reactions (ADRs) among healthcare professionals and patients is also expected to fuel the growth of this market over the next few years.
Industry Growth Insights published a new data on “Drug Safety Solutions and Pharmacovigilance Market”. The research report is titled “Drug Safety Solutions and Pharmacovigilance Market research by Types (Standard Form, Customized Form, Drug Safety Solutions and Pharmacovigilanc), By Applications (Biotechnology and Pharmaceuticals, Contract Research Organization (CROS), Hospital, KPO / BPO, Healthcare Institutions, Others), By Players/Companies Pharmaceutical Product Development, LLC, Drug Safety Solutions Limited, C3i, Worldwide Clinical Trials, Bioclinica, United Biosource LLC, Ennov, AB Cube, Covance Inc., Accenture, PRA Health Sciences, Inc., Ergomed, IQVIA, Genpact, Cognizant, Parexel International Corporation, ArisGlobal, ICON plc, Oracle, Syneos Health, Drug Safety Solutions and Pharmacovigilanc”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Drug Safety Solutions and Pharmacovigilance Market Research Report
By Type
Standard Form, Customized Form, Drug Safety Solutions and Pharmacovigilanc
By Application
Biotechnology and Pharmaceuticals, Contract Research Organization (CROS), Hospital, KPO / BPO, Healthcare Institutions, Others
By Companies
Pharmaceutical Product Development, LLC, Drug Safety Solutions Limited, C3i, Worldwide Clinical Trials, Bioclinica, United Biosource LLC, Ennov, AB Cube, Covance Inc., Accenture, PRA Health Sciences, Inc., Ergomed, IQVIA, Genpact, Cognizant, Parexel International Corporation, ArisGlobal, ICON plc, Oracle, Syneos Health, Drug Safety Solutions and Pharmacovigilanc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Drug Safety Solutions and Pharmacovigilance Market Report Segments:
The global Drug Safety Solutions and Pharmacovigilance market is segmented on the basis of:
Types
Standard Form, Customized Form, Drug Safety Solutions and Pharmacovigilanc
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biotechnology and Pharmaceuticals, Contract Research Organization (CROS), Hospital, KPO / BPO, Healthcare Institutions, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pharmaceutical Product Development, LLC
- Drug Safety Solutions Limited
- C3i
- Worldwide Clinical Trials
- Bioclinica
- United Biosource LLC
- Ennov
- AB Cube
- Covance Inc.
- Accenture
- PRA Health Sciences, Inc.
- Ergomed
- IQVIA
- Genpact
- Cognizant
- Parexel International Corporation
- ArisGlobal
- ICON plc
- Oracle
- Syneos Health
- Drug Safety Solutions and Pharmacovigilanc
Highlights of The Drug Safety Solutions and Pharmacovigilance Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Standard Form
- Customized Form
- Drug Safety Solutions and Pharmacovigilanc
- By Application:
- Biotechnology and Pharmaceuticals
- Contract Research Organization (CROS)
- Hospital
- KPO / BPO
- Healthcare Institutions
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Drug Safety Solutions and Pharmacovigilance Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Drug Safety Solutions is a global pharmaceutical safety company. Pharmacovigilance is the practice of monitoring the safety of drugs and other medical products.
Some of the major players in the drug safety solutions and pharmacovigilance market are Pharmaceutical Product Development, LLC, Drug Safety Solutions Limited, C3i, Worldwide Clinical Trials, Bioclinica, United Biosource LLC, Ennov, AB Cube, Covance Inc., Accenture, PRA Health Sciences, Inc., Ergomed, IQVIA, Genpact, Cognizant, Parexel International Corporation, ArisGlobal, ICON plc, Oracle, Syneos Health, Drug Safety Solutions and Pharmacovigilanc.
The drug safety solutions and pharmacovigilance market is expected to register a CAGR of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Drug Safety Solutions and Pharmacovigilance Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Drug Safety Solutions and Pharmacovigilance Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Drug Safety Solutions and Pharmacovigilance Market - Supply Chain
4.5. Global Drug Safety Solutions and Pharmacovigilance Market Forecast
4.5.1. Drug Safety Solutions and Pharmacovigilance Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Drug Safety Solutions and Pharmacovigilance Market Size (000 Units) and Y-o-Y Growth
4.5.3. Drug Safety Solutions and Pharmacovigilance Market Absolute $ Opportunity
5. Global Drug Safety Solutions and Pharmacovigilance Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Drug Safety Solutions and Pharmacovigilance Market Size and Volume Forecast by Type
5.3.1. Standard Form
5.3.2. Customized Form
5.3.3. Drug Safety Solutions and Pharmacovigilanc
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Drug Safety Solutions and Pharmacovigilance Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Drug Safety Solutions and Pharmacovigilance Market Size and Volume Forecast by Application
6.3.1. Biotechnology and Pharmaceuticals
6.3.2. Contract Research Organization (CROS)
6.3.3. Hospital
6.3.4. KPO / BPO
6.3.5. Healthcare Institutions
6.3.6. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Drug Safety Solutions and Pharmacovigilance Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Drug Safety Solutions and Pharmacovigilance Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Drug Safety Solutions and Pharmacovigilance Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Drug Safety Solutions and Pharmacovigilance Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Drug Safety Solutions and Pharmacovigilance Demand Share Forecast, 2019-2026
9. North America Drug Safety Solutions and Pharmacovigilance Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Drug Safety Solutions and Pharmacovigilance Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Drug Safety Solutions and Pharmacovigilance Market Size and Volume Forecast by Application
9.4.1. Biotechnology and Pharmaceuticals
9.4.2. Contract Research Organization (CROS)
9.4.3. Hospital
9.4.4. KPO / BPO
9.4.5. Healthcare Institutions
9.4.6. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Drug Safety Solutions and Pharmacovigilance Market Size and Volume Forecast by Type
9.7.1. Standard Form
9.7.2. Customized Form
9.7.3. Drug Safety Solutions and Pharmacovigilanc
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Drug Safety Solutions and Pharmacovigilance Demand Share Forecast, 2019-2026
10. Latin America Drug Safety Solutions and Pharmacovigilance Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Drug Safety Solutions and Pharmacovigilance Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Drug Safety Solutions and Pharmacovigilance Market Size and Volume Forecast by Application
10.4.1. Biotechnology and Pharmaceuticals
10.4.2. Contract Research Organization (CROS)
10.4.3. Hospital
10.4.4. KPO / BPO
10.4.5. Healthcare Institutions
10.4.6. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Drug Safety Solutions and Pharmacovigilance Market Size and Volume Forecast by Type
10.7.1. Standard Form
10.7.2. Customized Form
10.7.3. Drug Safety Solutions and Pharmacovigilanc
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Drug Safety Solutions and Pharmacovigilance Demand Share Forecast, 2019-2026
11. Europe Drug Safety Solutions and Pharmacovigilance Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Drug Safety Solutions and Pharmacovigilance Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Drug Safety Solutions and Pharmacovigilance Market Size and Volume Forecast by Application
11.4.1. Biotechnology and Pharmaceuticals
11.4.2. Contract Research Organization (CROS)
11.4.3. Hospital
11.4.4. KPO / BPO
11.4.5. Healthcare Institutions
11.4.6. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Drug Safety Solutions and Pharmacovigilance Market Size and Volume Forecast by Type
11.7.1. Standard Form
11.7.2. Customized Form
11.7.3. Drug Safety Solutions and Pharmacovigilanc
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Drug Safety Solutions and Pharmacovigilance Demand Share, 2019-2026
12. Asia Pacific Drug Safety Solutions and Pharmacovigilance Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Drug Safety Solutions and Pharmacovigilance Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Drug Safety Solutions and Pharmacovigilance Market Size and Volume Forecast by Application
12.4.1. Biotechnology and Pharmaceuticals
12.4.2. Contract Research Organization (CROS)
12.4.3. Hospital
12.4.4. KPO / BPO
12.4.5. Healthcare Institutions
12.4.6. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Drug Safety Solutions and Pharmacovigilance Market Size and Volume Forecast by Type
12.7.1. Standard Form
12.7.2. Customized Form
12.7.3. Drug Safety Solutions and Pharmacovigilanc
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Drug Safety Solutions and Pharmacovigilance Demand Share, 2019-2026
13. Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size and Volume Forecast by Application
13.4.1. Biotechnology and Pharmaceuticals
13.4.2. Contract Research Organization (CROS)
13.4.3. Hospital
13.4.4. KPO / BPO
13.4.5. Healthcare Institutions
13.4.6. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size and Volume Forecast by Type
13.7.1. Standard Form
13.7.2. Customized Form
13.7.3. Drug Safety Solutions and Pharmacovigilanc
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Drug Safety Solutions and Pharmacovigilance Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Drug Safety Solutions and Pharmacovigilance Market: Market Share Analysis
14.2. Drug Safety Solutions and Pharmacovigilance Distributors and Customers
14.3. Drug Safety Solutions and Pharmacovigilance Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Pharmaceutical Product Development, LLC
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Drug Safety Solutions Limited
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. C3i
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Worldwide Clinical Trials
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Bioclinica
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. United Biosource LLC
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Ennov
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. AB Cube
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Covance Inc.
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Accenture
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. PRA Health Sciences, Inc.
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Ergomed
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. IQVIA
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Genpact
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Cognizant
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Parexel International Corporation
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. ArisGlobal
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. ICON plc
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. Oracle
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. Syneos Health
&nb